Development of a Stochastic Individual Path (SIP) Model for Predicting the Deposition of Pharmaceutical Aerosols: Effects of Turbulence, Polydisperse Aerosol Size, and Evaluation of Multiple Lung Lobes
Open Access
- 6 July 2012
- journal article
- research article
- Published by Informa UK Limited in Aerosol Science and Technology
- Vol. 46 (12), 1271-1285
- https://doi.org/10.1080/02786826.2012.708799
Abstract
In this study, a new computational fluid dynamics (CFD) modeling approach for pharmaceutical aerosols is further developed by evaluating the effects of turbulence, polydisperse aerosol size distribution, and multiple lung lobes on deposition in the mouth–throat (MT) and entire tracheobronchial (TB) airways. To evaluate a range of respiratory drug delivery conditions, a model dry powder inhaler (DPI; NovolizerTM) and a model spray soft-mist inhaler (SMI; RespimatTM) were considered. The respiratory geometry consisted of a previously developed characteristic MT and complete upper TB geometry through the third bifurcation (B3). More distal TB airways were simulated using stochastic individual path (SIP) models extending into each of the five lung lobes through bifurcation B15. Based on comparisons with new in vitro deposition data, results indicated that the low Reynolds number (LRN) k–ω turbulence model with near-wall corrections for anisotropic turbulence and velocity conditions accurately predicted deposited drug mass from both inhalers. Simulating the polydisperse aerosol size distribution had a large impact on overall deposited drug mass compared with a monodisperse approximation. However, a new equivalent mass median diameter (MMD), calculated as MMDeq = 1.25 × MMD, was shown to provide a good monodisperse estimate of the aerosol deposition from both inhalers considered in this study used with different inhalation flow conditions in the SIP models. Large variations in deposition were observed among the five lung lobes. However, deposition in the left lower lobe (scaled by a factor of 5) was found to be characteristic of total lobar deposition in the range of B4–B15 and allowed for the simulation of only one lobe. Implementing the approximations of an equivalent MMD and simulating deposition in one characteristic lung lobe increased the efficiency of the airway CFD simulations by over 25 times at the expense of a maximum 12% relative error compared with the more exact simulations. As an example of model utility, results indicated that the state-of-the-art SMI improved delivery efficiency of drug by a factor of 1.5 in the upper TB region and by over an order of magnitude in the lower TB airways compared with a commonly used high quality DPI. Copyright 2012 American Association for Aerosol ResearchKeywords
This publication has 58 references indexed in Scilit:
- In VitroTests for Aerosol Deposition. I: Scaling a Physical Model of the Upper Airways to Predict Drug Deposition Variation in Normal HumansJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2012
- Airflow Distribution in the Human Lung and its Influence on Particle DepositionInhalation Toxicology, 2006
- A review of the development of Respimat® Soft Mist™ InhalerInternational Journal of Pharmaceutics, 2004
- Novolizer??Drugs, 2003
- Computation of local enhancement factors for the quantification of particle deposition patterns in airway bifurcationsJournal of Aerosol Science, 1998
- Low Reynolds number turbulence modeling of blood flow in arterial stenosesPublished by Elsevier BV ,1998
- Estimating the Type of Hygroscopic Behavior Exhibited by Aqueous DropletsJournal of Aerosol Medicine, 1998
- Measurements of Airway Dimensions and Calculation of Mass Transfer Characteristics of the Human Oral PassageJournal of Biomechanical Engineering, 1997
- Physiologically realistic models of bronchial airway bifurcationsJournal of Aerosol Science, 1995
- Aspects of Computer Simulation of Liquid-Fueled CombustorsJournal of Energy, 1983